Copyright
©The Author(s) 2020.
World J Gastrointest Endosc. Sep 16, 2020; 12(9): 285-296
Published online Sep 16, 2020. doi: 10.4253/wjge.v12.i9.285
Published online Sep 16, 2020. doi: 10.4253/wjge.v12.i9.285
Number | Stent type, n = 70, n (%) | P value | ||
HCMS | FCMS | UMS | ||
Gender | 0.86 | |||
Male | 45 (64.3) | 46 (65.7) | 48 (68.6) | |
Female | 25 (33.7) | 24 (34.3) | 22 (31.4) | |
Age, median (range) | 67 (39-84) | 65 (45-82) | 64 (42-83) | 0.37 |
Cholecystectomy | 16 (22.9) | 17 (24.3) | 17 (24.3) | 0.97 |
Cause of distal biliary obstruction | 0.99 | |||
Cancer pancreas | 47 (67.1) | 48 (68.6) | 46 (65.7) | |
Distal cholangiocarcinoma | 9 (12.9) | 10 (14.3) | 12 (17.2) | |
Gallbladder cancer | 5 (7.1) | 4 (5.7) | 5 (7.1) | |
Ampullary cancer | 9 (12.9) | 8 (11.4) | 7 (10.0) | |
Laboratory investigations, mean ± SD | ||||
Serum total bilirubin, mg/dL | 15 ± 8.7 | 14.5 ± 5.6 | 16.1 ± 7.7 | 0.43 |
Serum direct bilirubin, mg/dL | 13 ± 6.4 | 12.9 ± 4.1 | 13.2 ± 6.8 | 0.95 |
SGPT, UI/L | 112 ± 90 | 110.7 ± 96.5 | 120.2 ± 90.3 | 0.80 |
SGOT, UI/L | 146 ± 110.2 | 129.3 ± 106.2 | 142.4 ± 112.1 | 0.64 |
Albumin | 4.1 ± 1.3 | 3.9 ± 1.4 | 3.8 ± 1.6 | 0.46 |
INR | 1.3 ± 0.2 | 1.2 ± 0.2 | 1.2 ± 0.2 | 0.94 |
Imaging | ||||
Liver metastasis | 2 (2.9) | 1 (1.4) | 1 (1.4) | 0.78 |
PVT | 1 (1.4) | 1 (1.4) | 2 (2.9) | 0.78 |
Ascites | 1 (1.4) | 2 (2.9) | 1 (1.4) | 0.78 |
Clinical presentation | ||||
Jaundice | 57 (81.4) | 55 (78.6) | 55 (78.6) | 0.89 |
Pain | 34 (48.6) | 31 (44.3) | 34 (48.6) | 0.84 |
Fever | 9 (12.9) | 8 (11.4) | 9 (12.9) | 0.96 |
Itching | 16 (22.9) | 15 (21.4) | 18 (25.7) | 0.83 |
Anorexia | 27 (38.6) | 26 (37.1) | 20 (28.6) | 0.41 |
Weight loss | 44 (62.9) | 42 (60.0) | 45 (64.3) | 0.87 |
Cholangitis | 12 (17.1) | 10 (14.3) | 13 (18.6) | 0.79 |
Operative time, time passed from selective cannulation till the end of procedure | 4.5 ± 2.5 min | 4 ± 3 min | 5 ± 3.5 min | 0.15 |
X-ray dose, time passed from selective cannulation till the end of procedure | 2 ± 1 min | 2 ± 1.5 min | 2 ± 1 min | NA |
Antibiotic | 0.87 | |||
No | 44 (62.9) | 42 (60.0) | 45 (64.3) | |
Yes | 26 (37.1) | 28 (40.0) | 25 (35.7) | |
Previous chemotherapy | 0.9 | |||
No | 59 (84.3) | 58 (82.9) | 57 (81.4) | |
Yes | 11 (15.7) | 12 (17.1) | 13 (18.6) | |
Radiotherapy | 0.36 | |||
No | 69 (98.6) | 70 (100) | 68 (97.1) | |
Yes | 1 (1.4) | 0 (0.0) | 2 (2.9) | |
Post-stenting chemotherapy | 0.91 | |||
No | 55 (78.6) | 56 (80.0) | 57 (81.4) | |
Yes | 15 (21.4) | 14 (20.0) | 13 (19.6) |
- Citation: Elshimi E, Morad W, Elshaarawy O, Attia A. Optimization of biliary drainage in inoperable distal malignant strictures. World J Gastrointest Endosc 2020; 12(9): 285-296
- URL: https://www.wjgnet.com/1948-5190/full/v12/i9/285.htm
- DOI: https://dx.doi.org/10.4253/wjge.v12.i9.285